Title | Type | SJR | H index | Total Docs. (2013) | Total Docs. (3years) | Total Refs. (2013) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2013) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Pharmacological Reviews | journal | 12.114 Q1 | 254 | 36 | 91 | 13930 | 2347 | 91 | 20.90 | 386.94 | |
2 | Medicinal Research Reviews | journal | 2.746 Q1 | 150 | 35 | 87 | 7834 | 749 | 85 | 8.31 | 223.83 | |
3 | Pharmacology and Therapeutics | journal | 3.622 Q1 | 233 | 105 | 312 | 21154 | 3026 | 311 | 9.21 | 201.47 | |
4 | Reviews of Physiology Biochemistry and Pharmacology | journal | 1.754 Q1 | 70 | 5 | 10 | 931 | 41 | 10 | 4.10 | 186.20 | |
5 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 0.920 Q1 | 82 | 15 | 34 | 2655 | 135 | 34 | 4.26 | 177.00 | |
6 | Natural Product Reports | journal | 3.094 Q1 | 211 | 64 | 237 | 11257 | 2411 | 231 | 10.36 | 175.89 | |
7 | Journal of Forensic Medicine and Toxicology | journal | 19 | 1 | 107 | 168 | 11 | 107 | 0.09 | 168.00 | ||
8 | Journal of Experimental Pharmacology | journal | 0.129 Q4 | 23 | 1 | 3 | 166 | 2 | 3 | 0.50 | 166.00 | |
9 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.615 Q1 | 99 | 14 | 74 | 2197 | 389 | 68 | 5.04 | 156.93 | |
10 | Recent Patents on Anti-Cancer Drug Discovery | journal | 1.162 Q1 | 52 | 24 | 77 | 3422 | 229 | 71 | 2.84 | 142.58 | |
11 | Journal of Receptor, Ligand and Channel Research | journal | 0.481 Q3 | 13 | 2 | 12 | 279 | 23 | 11 | 0.43 | 139.50 | |
12 | Current Neuropharmacology | journal | 0.951 Q2 | 103 | 48 | 170 | 6542 | 547 | 161 | 2.60 | 136.29 | |
13 | Advanced Drug Delivery Reviews | journal | 4.414 Q1 | 366 | 168 | 421 | 21777 | 6088 | 377 | 13.50 | 129.63 | |
14 | Critical Reviews in Toxicology | journal | 1.948 Q1 | 129 | 47 | 121 | 5822 | 868 | 113 | 6.59 | 123.87 | |
15 | Drug Metabolism Reviews | journal | 1.739 Q1 | 108 | 33 | 95 | 4051 | 593 | 92 | 6.20 | 122.76 | |
16 | Annual Review of Pharmacology and Toxicology | journal | 10.782 Q1 | 224 | 27 | 61 | 3273 | 1517 | 61 | 21.39 | 121.22 | |
17 | Cellular and Molecular Life Sciences | journal | 3.339 Q1 | 261 | 301 | 893 | 36153 | 5840 | 887 | 6.40 | 120.11 | |
18 | Drug Resistance Updates | journal | 3.734 Q1 | 132 | 10 | 72 | 1170 | 828 | 67 | 10.58 | 117.00 | |
19 | Current Medicinal Chemistry | journal | 1.373 Q1 | 202 | 359 | 1223 | 41513 | 5433 | 1164 | 4.02 | 115.64 | |
20 | Current Vascular Pharmacology | journal | 0.783 Q2 | 69 | 94 | 268 | 10596 | 775 | 248 | 2.82 | 112.72 | |
21 | Recent Patents on CNS Drug Discovery | journal | 0.940 Q2 | 36 | 18 | 64 | 2003 | 181 | 57 | 2.90 | 111.28 | |
22 | Current Pharmaceutical Design | journal | 1.295 Q1 | 183 | 659 | 1399 | 71581 | 5281 | 1284 | 3.55 | 108.62 | |
23 | Handbook of Experimental Pharmacology | journal | 1.347 Q1 | 110 | 78 | 370 | 8443 | 1462 | 346 | 3.84 | 108.24 | |
24 | Recent Patents on Endocrine, Metabolic and Immune Drug Discovery | journal | 0.424 Q3 | 28 | 23 | 74 | 2456 | 126 | 72 | 2.38 | 106.78 | |
25 | Current Cancer Drug Targets | journal | 1.585 Q1 | 103 | 82 | 269 | 8657 | 1036 | 249 | 3.79 | 105.57 | |
26 | Current Drug Metabolism | journal | 1.138 Q1 | 122 | 100 | 302 | 10414 | 1284 | 266 | 3.59 | 104.14 | |
27 | Expert Opinion on Drug Discovery | journal | 1.160 Q1 | 84 | 103 | 272 | 10456 | 986 | 272 | 3.68 | 101.51 | |
28 | Journal of Applied Research | journal | 0.148 Q4 | 23 | 2 | 40 | 203 | 14 | 39 | 0.17 | 101.50 | |
29 | Vaccines | journal | 85 | 2 | 0 | 202 | 0 | 0 | 0.00 | 101.00 | ||
30 | Current Topics in Medicinal Chemistry | journal | 1.268 Q1 | 133 | 241 | 600 | 23758 | 2286 | 526 | 3.62 | 98.58 | |
31 | Pharmaceuticals | journal | 0.590 Q1 | 87 | 72 | 352 | 7009 | 642 | 349 | 1.34 | 97.35 | |
32 | Antibodies | journal | 42 | 31 | 17 | 3013 | 18 | 16 | 1.06 | 97.19 | ||
33 | Recent advances in inflammation & allergy drug discovery | journal | 37 | 23 | 74 | 2232 | 146 | 72 | 2.16 | 97.04 | ||
34 | Advances in Pharmacology | journal | 2.633 Q1 | 86 | 40 | 106 | 3814 | 517 | 1 | 5.30 | 95.35 | |
35 | Current Molecular Pharmacology | journal | 1.455 Q1 | 49 | 20 | 71 | 1907 | 251 | 65 | 2.88 | 95.35 | |
36 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.199 Q3 | 29 | 12 | 34 | 1144 | 19 | 0 | 0.58 | 95.33 | |
37 | Expert Opinion on Emerging Drugs | journal | 0.951 Q2 | 54 | 40 | 136 | 3787 | 434 | 134 | 3.44 | 94.68 | |
38 | Neurotherapeutics | journal | 2.471 Q1 | 136 | 71 | 188 | 6671 | 1188 | 174 | 4.48 | 93.96 | |
39 | EPMA Journal | journal | 0.341 Q3 | 52 | 8 | 120 | 745 | 172 | 108 | 1.40 | 93.13 | |
40 | Progress in Medicinal Chemistry | journal | 0.983 Q2 | 38 | 6 | 17 | 543 | 50 | 1 | 3.55 | 90.50 | |
41 | Recent Advances in Anti-Infective Drug Discovery | journal | 38 | 24 | 71 | 2171 | 145 | 69 | 2.10 | 90.46 | ||
42 | Expert Opinion on Therapeutic Targets | journal | 2.023 Q1 | 106 | 130 | 359 | 11733 | 1726 | 355 | 4.86 | 90.25 | |
43 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.495 Q3 | 45 | 26 | 75 | 2332 | 108 | 69 | 1.10 | 89.69 | |
44 | Mini-Reviews in Medicinal Chemistry | journal | 0.939 Q2 | 107 | 164 | 355 | 14556 | 1230 | 337 | 3.42 | 88.76 | |
45 | Current Gene Therapy | journal | 2.047 Q1 | 80 | 46 | 142 | 4073 | 754 | 126 | 5.45 | 88.54 | |
46 | Expert Opinion on Therapeutic Patents | journal | 1.188 Q1 | 88 | 112 | 330 | 9802 | 1165 | 324 | 3.50 | 87.52 | |
47 | Molecular and Cellular Pharmacology | journal | 0.849 Q1 | 28 | 10 | 59 | 868 | 121 | 53 | 1.50 | 86.80 | |
48 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.906 Q2 | 100 | 128 | 368 | 11082 | 1279 | 366 | 3.49 | 86.58 | |
49 | Expert Opinion on Drug Delivery | journal | 1.482 Q1 | 133 | 128 | 326 | 11044 | 1722 | 324 | 4.57 | 86.28 | |
50 | Current Drug Targets | journal | 1.548 Q1 | 119 | 174 | 546 | 14997 | 2193 | 496 | 3.67 | 86.19 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®